[Sinus balloon dilation for treatment of chronic sinusitis: a systematic review and Meta-analysis].

Objective:To systematically assess the efficacy of sinus balloon dilation（SBCD） for patients with chronic rhinosinusitis（CRS）. Method:To research the references whose the contents were related to the randomized controlled trials of sinus balloon dilation for treatment of chronic sinusitis from PubMed, Embase, Cochrane Library, WanFang, CNKI and other databases from January 2000 to June 2019. Assessed the quality and extracted the data of these included references and made Meta analysis by RevMan5.3 software. Result:A total of 11 references in English and Chinese were included. Result:Of Meta analysis showed that the difference had no statistical significance between the SNOT-20 score which were based on the statistics measured 3 months later and 6 months later [3 months later, SMD=-0.30, 95%CI（-1.01-0.41）, P=0.40, 6 months later, SMD=-0.53, 95%CI（-3.22-2.16）, P=0.70]and the score in the control group. Lund-Mackay CT score [SMD＝-0.69, 95%CI（-0.72--0.66, P<0.00001） ]and VAS symptom score [SMD＝-1.67, 95%CI（-1.91--1.44）, P<0.00001]following SBCD versus FESS in the treatment of CRS had statistical significance. Besides, SBCD had a lower incidence [OR=0.29, 95%CI（0.14-0.59）, P=0.0007]to develop postoperative complications compared with that in the control group. Conclusion:Balloon dilation of sinuses can significantly relieve the symptoms of patients with chronic sinusitis, this effect is equal or even better. Moreover, the incidence of developing the postoperative complications is lower, which SBCD of CRS is worthy of clinical popularization.